Results 11 to 20 of about 2,185,702 (211)
Bangladesh Journal of Pharmacology, 2018 Anti-snake venom therapy is the only treatment for snake bite but leads to acute and chronic conditions which may be severe. The medicinal plants have gained importance over years to find an effective alternative to anti-snake venom.
Shwetha Vasudev +3 more
doaj +4 more sources
Uveitis following anti-snake venom therapy [PDF]
Journal of Venomous Animals and Toxins including Tropical Diseases, 2007 Snakebite is a common medical emergency in the tropics, causing multisystemic involvement. Ophthalmic manifestations after snakebite have included ptosis and ophthalmoplegia. Uveitis as an immunological complication following therapy with anti-snake venom (ASV) serum has been rarely reported in literature. We reported two patients who developed uveitis
S. G. Nayak +3 more
core +7 more sources
Caralluma dalzielii as a potential anti-venom agent against Naja nigricollis envenomation in Wistar rats [PDF]
Brazilian Journal of Pharmaceutical SciencesThe World Health Organization has listed Snakebite Envenomation as a significantly ignored tropical disease with a worldwide annual snakebite affecting millions of people, especially in Africa.
Chinenye Jane Ugwah-Oguejiofor +3 more
doaj +3 more sources
The Study on the Snake by TOXICON
Journal of Pharmacopuncture, 2003 The study was carried out to investigate the researches of Snake which was published papers in the TOXICON(1990-2.000), one of the most famous Journal of toxicology. And the results were as follows: 1. The number related with Snake is 195papers.
Sung-wook Kim, Ki-Rok Kwon, Kwang-Ho Kim
doaj +2 more sources
Anti-Snake Venom Property of Medicinal Plants: A Comprehensive Review of Literature
Brazilian Journal of Pharmaceutical Sciences, 2022 Abstract Snakebite is one of the major health issues posing considerable morbidity and mortality. According to an estimate of World Health Organization (WHO) (World health organization, 2021) approximately 5 million people are bitten by several species of snakes resulting in up to 2.5 million envenomation cases annually.
Aroosa Liaqat +5 more
openaire +3 more sources
Snake Bite: Clinical Profile and Evaluation of Effective Anti-Snake Venom Dose [PDF]
Journal of Rawalpindi Medical College, 2010 Background: To determine the optimal dose of antisnake venom required to treat hemotoxic snake bite more effectively. Methods: In this interventional study, out of 52 patients 46 patients with the features of systemic envenomation .i.e.
Asif Raza Bhatti
doaj +1 more source
Viper Venom and Synthetic Peptides: Emerging Active Ingredients in Anti-Ageing Cosmeceuticals
Applied SciencesThe animal kingdom, particularly reptiles, is widely recognized as a valuable source of peptides and proteins with applications in medicine, the pharmaceutical industry and, more recently, the cosmetic industry.
Dana Georgiana Moisă +5 more
doaj +2 more sources
Proteopeptidomic, Functional and Immunoreactivity Characterization of Bothrops moojeni Snake Venom: Influence of Snake Gender on Venom Composition [PDF]
Toxins, 2018 Venom composition varies across snakes from all taxonomic levels and is influenced by the snakes’ age, habitat, diet, and sexual dimorphism. The present study reports the first in-depth investigation of venom composition in male and female Bothrops
Fernanda Gobbi Amorim +5 more
doaj +2 more sources
Anti-snake Venom-Induced Kounis Syndrome: A Unique Case in the Emergency Department. [PDF]
Cureus, 2022 Kounis syndrome is the concurrence of acute coronary syndromes associated with allergic or hypersensitivity and anaphylactic or anaphylactoid triggers. Although it is not a rare diagnosis, the different presentations and afflictions of all ages, sex, and racial groups make it a diagnostic challenge.
Verma A +4 more
europepmc +3 more sources
Is anti-snake venom required for all snakebites: A case report. [PDF]
Clin Case Rep, 2020 AbstractThe classification of snakebite is based on clinical examination and laboratory tests. In cases, of suspected hemotoxic snakebite, the anti‐snakebite venom (ASV) is administered based on 20‐minute whole blood clotting time. However, the use of ASV should be guided by the presence of bleeding diathesis along with raised clotting time.
Dorji T.
europepmc +4 more sources